Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Ma, Jian Da ^a   Zhou, Jing Jing ^a   Zheng, Dong Hui ^a   Chen, Le Feng ^a   Mo, Ying Qian ^a   Wei, Xiu Ning ^a   Yang, Li Juan ^a   Dai, Lie ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD68 ANTIGEN; CHINESE DRUG; CORTICOSTEROID; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; STROMELYSIN; BIOLOGICAL MARKER;

ADULT; ARTHRALGIA; ARTHROPATHY; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE DURATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL; ORTHOPEDIC ARTHROPATHY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STROMA; SYNOVITIS; SYNOVIUM; ARTHRITIS, RHEUMATOID; BLOOD; ENZYMOLOGY;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; SYNOVITIS;

EID: 84930001832     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/179284     Document Type: Article

References (36)

1. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, "Rheumatoid arthritis, " The Lancet, vol. 376, no. 9746, pp. 1094-1108, 2010.
2. Y. Mo, L. Dai, D. Zheng et al. , "Synovial infiltration with CD79apositive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis, " Journal of Rheumatology, vol. 38, no. 11, pp. 2301-2308, 2011.
3. C. Pitzalis, S. Kelly, and F. Humby, "New learnings on the pathophysiology of RA from synovial biopsies, " Current Opinion in Rheumatology, vol. 25, no. 3, pp. 334-344, 2013.
4. M. Rooney, D. Condell, W. Quinlan et al. , "Analysis of the histologic variation of synovitis in rheumatoid arthritis, " Arthritis and Rheumatism, vol. 31, no. 8, pp. 956-963, 1988.
5. T. J. Smeets, R. J. Dolhain, F. C. Breedveld et al. , "Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis, " Journal of Pathology, vol. 186, no. 1, pp. 75-81, 1998.
6. F. Koizumi, H. Matsuno, K. Wakaki, Y. Ishii, Y. Kurashige, and H. Nakamura, "Synovitis in rheumatoid arthritis: Scoring of characteristic histopathological features, " Pathology International, vol. 49, no. 4, pp. 298-304, 1999.
7. V. Krenn, L. Morawietz, T. Haupl, J. Neidel, I. Petersen, and A. Konig, "Grading of chronic synovitis-a histopathological grading systemformolecular and diagnostic pathology, " Pathology Research and Practice, vol. 198, no. 5, pp. 317-325, 2002.
8. J. Wut, M. W. Lark, L. E. Chun, and D. R. Eyre, "Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage, "The Journal of Biological Chemistry, vol. 266, no. 9, pp. 5625-5628, 1991.
9. M. M. T. M. Ally, B. Hodkinson, P. W. A. Meyer, E. Musenge, M. Tikly, and R. Anderson, "Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis, " Mediators of Inflammation, vol. 2013, Article ID 183653, 6 pages, 2013.
10. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al. , "The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, " Arthritis and Rheumatism, vol. 31, no. 3, pp. 315-324, 1988.
11. D. Aletaha, T. Neogi, A. J. Silman et al. , "2010 Rheumatoid arthritis classification criteria: an AmericanCollege ofRheumatology/ European League against Rheumatism collaborative initiative, " Arthritis & Rheumatism, vol. 62, no. 9, pp. 2569-2581, 2010.
12. J. Anderson, L. Caplan, J. Yazdany et al. , "Rheumatoid arthritis disease activity measures: American college of rheumatology recommendations for use in clinical practice, " Arthritis Care and Research, vol. 64, no. 5, pp. 640-647, 2012.
13. F. Pessler, L. Dai, C. Diaz-Torne et al. , "The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis, " Annals of the Rheumatic Diseases, vol. 67, no. 8, pp. 1184-1187, 2008.
14. E. T. Koh, A. Seow, L. Y. Pong et al. , "Cross cultural adaptation and validation of theChineseHealthAssessmentQuestionnaire for use in rheumatoid arthritis, " Journal of Rheumatology, vol. 25, no. 9, pp. 1705-1708, 1998.
15. H. R. Schumacher Jr. and J. P. Kulka, "Needle biopsy of the synovial membrane-experience with the Parker-Pearson technic, " The New England Journal of Medicine, vol. 286, no. 8, pp. 416-419, 1972.
16. M. G. H. van de Sande, D. M. Gerlag, B. M. Lodde et al. , "Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials, " Annals of the Rheumatic Diseases, vol. 70, no. 3, pp. 423-427, 2011.
17. V. Krenn, L. Morawietz, G.-R. Burmester et al. , "Synovitis score: discrimination between chronic low-grade and highgrade synovitis, " Histopathology, vol. 49, no. 4, pp. 358-364, 2006.
18. B. Bresnihan, G. Cunnane, P. Youssef, G. Yanni, O. Fitzgerald, and D. Mulherin, "Microscopic measurement of synovialmembrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis, " British Journal of Rheumatology, vol. 37, no. 6, pp. 636-642, 1998.
19. D. Aletaha, F. Alasti, and J. S. Smolen, "Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression, " Annals of the Rheumatic Diseases, vol. 70, no. 11, pp. 1975-1980, 2011.
20. P. Roux-Lombard, K. Eberhardt, T. Saxne, J.-M. Dayer, and F. A. Wollheim, "Cytokines, metalloproteinases, their inhibitors and cartilage oligomericmatrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study, " Rheumatology, vol. 40, no. 5, pp. 544-551, 2001.
21. T. Rooney, P. Roux-Lombard, D. J. Veale, O. FitzGerald, J. Dayer, and B. Bresnihan, "Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade, " Annals of the Rheumatic Diseases, vol. 69, no. 4, pp. 706-714, 2010.
22. S. Sasaki, H. Iwata, N. Ishiguro, K. Obata, and T. Miura, "Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis, " Clinical Rheumatology, vol. 13, no. 2, pp. 228-233, 1994.
23. A. Kobayashi, S. Naito, H. Enomoto et al. , "Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis, " Archives of Pathology and Laboratory Medicine, vol. 131, no. 4, pp. 563-570, 2007.
24. I. B. McInnes and G. Schett, "The pathogenesis of rheumatoid arthritis, " New England Journal of Medicine, vol. 365, no. 23, pp. 2205-2219, 2011.
25. W. Zhu, L. Meng, C. Jiang et al. , "Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts, " Arthritis Research and Therapy, vol. 13, no. 3, article R103, 2011.
26. D. Baeten, F. de Keyser, P. Demetter et al. , "Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity, " Annals of the Rheumatic Diseases, vol. 59, no. 12, pp. 945-953, 2000.
27. Y. Okada, N. Takeuchi, K. Tomita, I. Nakanishi, and H. Nagase, "Immunolocalisation of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis, " Annals of the Rheumatic Diseases, vol. 48, no. 8, pp. 645-653, 1989.
28. R. Cascao, H. S. Rosario, M. M. Souto-Carneiro, and J. E. Fonseca, "Neutrophils in rheumatoid arthritis: more than simple final effectors, " Autoimmunity Reviews, vol. 9, no. 8, pp. 531-535, 2010.
29. C. H. Wang, J. Y. Dai, L. Wang et al. , "Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes, " Journal of Cellular and Molecular Medicine, vol. 15, no. 4, pp. 850-860, 2011.
30. E. Slansky, J. Li, T. Haupl, L. Morawietz, V. Krenn, and F. Pessler, "Quantitative determination of the diagnostic accuracy of the synovitis score and its components, " Histopathology, vol. 57, no. 3, pp. 436-443, 2010.
31. M. Houseman, C. Potter, N. Marshall et al. , "Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up, " Arthritis Research andTherapy, vol. 14, no. 1, article R30, 2012.
32. J. D. Ma, X. Ou-Yang, D. H. Zheng et al. , "Combined detection of serum matrix metalloproteinase-3 and C-reactive protien in disease activity measurement in female patients with rheumatoid arthritis, " Chinese Journal of Clinicians (Electronic Edition), vol. 8, pp. 3301-3305, 2013.
33. J. S. Smolen, D. M. F. M. van der Heijde, E. W. St. Clair et al. , "Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial, " Arthritis and Rheumatism, vol. 54, no. 3, pp. 702-710, 2006.
34. M. Ostergaard, C. Peterfy, P. Conaghan et al. , "OMERACT rheumatoid arthritismagnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system, " The Journal of Rheumatology, vol. 30, no. 6, pp. 1385-1386, 2003.
35. P. BOyesen, E. A. Haavardsholm, M. Ostergaard, D. Van Der Heijde, S. Sesseng, and T. K. Kvien, "MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression, " Annals of the Rheumatic Diseases, vol. 70, no. 3, pp. 428-433, 2011.
36. S. Sun, A. C. Bay-Jensen, M. A. Karsdal et al. , "The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases, " BMC Musculoskeletal Disorders, vol. 15, article 93, 2014.